Business Wire

MI-EATON-VEHICLE-GROUP

21.4.2022 12:32:13 CEST | Business Wire | Press release

Share
Eaton’s Vehicle Group Facilities Reducing Environmental Impact With New Technologies and Systems

Power management company Eaton today announced its Vehicle Group has certified 88% of its global facilities as “zero-waste-to-landfill” (ZWTL), having cut the amount of waste going into landfills by 55% since 2019. Eaton defines ZWTL as consistently achieving a landfill waste diversion rate of 98% through reuse, composting, recycling or incineration, but only if the heat generated by incineration was collected and used to create more energy than what was used in the incineration process.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220421005050/en/

“We are extremely proud of how we’ve come together to upgrade our manufacturing facilities, leveraging technology to improve energy efficiency, minimize environmental impact and bring us closer to a carbon-free future,” said Sunil Bhandari, vice president, Global Operations, Eaton’s Vehicle Group. “Our commitment to sustainability is part of our core mission to improve the quality of life and the environment for those who count on us today and in the decades to come.”

To reduce waste, the Vehicle Group is focused on four primary areas: reuse, recycle, waste to energy and waste to landfill.

Separating swarf from water and recycling keeps it from landfill

One of the key projects in these efforts is the Vehicle Group’s swarf grinding project, which is in the process of being implemented at all its global sites that perform grinding operations.

Swarf is a byproduct generated during metal-cutting processes when fluids such as oils, coolants and water are mixed with fine particles of metal and filtration media. Swarf is one of the most difficult waste streams to recycle, but the Vehicle Group has made great strides in diverting swarf waste from landfills.

Through vendor partnerships, the Vehicle Group deploys a mobile centrifuge process that separates the materials. The fluid then is reused in manufacturing processes, and the metal particles are recycled, resulting in cost savings. A swarf recycling trial in 2019 diverted 500 tons from the landfill, and work is ongoing to expand this solution to expedite ZWTL progress.

The Vehicle Group is finding reuse opportunities to eliminate sludge created during the plating process by recycling the metal content, which eliminates the need for disposal into a landfill. It is also working to develop a more efficient filtering process to remove sludge and reuse the water for further plating.

Additionally, significant progress is being made in the segregation of general trash. Trash is typically created from a lack of knowledge of recycling opportunities and the use of unrecyclable materials. In an effort to prevent paper, metal and recyclable plastics from going into the trash, the Vehicle Group is working to improve education around recycling opportunities and procedures. Along these same lines, the Vehicle Group is ensuring all packaging it uses is recyclable and is encouraging its suppliers to do the same.

“For these efforts to realize their full potential, we are educating our teams on correct recycling methods, and we are asking for input on how to identify issues and new areas of opportunity,” Bhandari said.

Water conservation efforts making a significant impact at global sites

Implementing several innovative initiatives, the Vehicle Group has lowered water consumption at its global sites by 14% since 2019, putting it well on its way to achieving its 2030 zero water discharge target.

To reduce water consumption and mitigate pollutants, the Vehicle Group is installing wastewater systems featuring ultrafiltration and reverse osmosis technologies at several of its facilities. The systems treat and reuse water for industrial purposes. Some facilities are also managing stormwater by increasing the permeability of their property, decreasing runoff rates to reduce erosion and planting native florae that don’t require watering. Additionally, automatic flow-sensor faucets are being installed at Vehicle Group global facilities to enable the reuse of chiller water used during daily operations.

Read more about Eaton’s commitment to sustainability in its latest Sustainability Report.

Learn more about how Eaton is helping its customers conserve resources and reduce their carbon footprint.

Eaton is an intelligent power management company dedicated to improving the quality of life and protecting the environment for people everywhere. We are guided by our commitment to do business right, to operate sustainably and to help our customers manage power — today and well into the future. By capitalizing on the global growth trends of electrification and digitalization, we’re accelerating the planet’s transition to renewable energy, helping to solve the world’s most urgent power management challenges, and doing what’s best for our stakeholders and all of society.

Founded in 1911, Eaton has been listed on the NYSE for nearly a century. We reported revenues of $19.6 billion in 2021 and serve customers in more than 170 countries. For more information, visit www.eaton.com . Follow us on Twitter and LinkedIn.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release

Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye